(Q37127413)

18 August 2017

1 reference

title

Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage (English)

1 reference

18 August 2017

2

Robert M Starke

1 reference

18 August 2017

5

E Sander Connolly

1 reference

18 August 2017

4

0 references

author name string

Mark Chwajol

series ordinal

1

1 reference

18 August 2017

Grace H Kim

series ordinal

3

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

418-426

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-008-9088-5

18 August 2017

exact match

0 references

cites work

Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Intracranial Aneurysms and Subarachnoid Hemorrhage. A Cooperative Study. Antifibrinolytic Therapy in Recent Onset Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Cerebral Thrombosis Associated with Amicar Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Rhabdomyolysis during treatment with epsilon-aminocaproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Antifibrinolytic Treatment in Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9088-5

Myopathy due to epsilon amino-caproic acid

21 January 2018

1 reference

12 December 2020

Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study

1 reference

12 December 2020

Biochemical changes after spontaneous subarachnoid haemorrhage. 3. Coagulation and lysis with special reference to recurrent haemorrhage

1 reference

12 December 2020

Myopathy from E-aminocaproic acid: a second case

1 reference

12 December 2020

Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

Echo-encephalographic study of ventricular dilatation after subarachnoid hemorrhage, with special reference to the effect of antifibrinolytic treatment

1 reference

12 December 2020

An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus

1 reference

12 December 2020

Early management of aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.

1 reference

12 December 2020

Acute Delirious State After ε-Amino Caproic Acid Administration

1 reference

12 December 2020

A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms

1 reference

12 December 2020

Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial

1 reference

12 December 2020

Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage.

1 reference

12 December 2020

Significance of "ultra-early" rebleeding in subarachnoid hemorrhage.

1 reference

12 December 2020

Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.

1 reference

12 December 2020

Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy

1 reference

12 December 2020

Antifibrinolytic Activity During Administration of Epsilon-Aminocaproic Acid

1 reference

12 December 2020

Tranexamic acid in the preoperative management of ruptured intracranial aneurysms

1 reference

12 December 2020

Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid

1 reference

12 December 2020

Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study

1 reference

12 December 2020

Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid

1 reference

12 December 2020

Tranexamic acid in subarachnoid hemorrhage. A double-blind study

1 reference

12 December 2020

Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis

1 reference

12 December 2020

Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?

1 reference

12 December 2020

Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy

1 reference

12 December 2020

Epsilon-aminocaproic acid myopathy. Report of a case and literature review

1 reference

12 December 2020

Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery

1 reference

12 December 2020

The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms

1 reference

12 December 2020

Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products

1 reference

12 December 2020

Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition

1 reference

12 December 2020

Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study

1 reference

12 December 2020

Treatment of subarachnoid hemorrhage: the ability of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity

1 reference

12 December 2020

Letter: Tranexamic acid and intracranial thrombosis

1 reference

12 December 2020

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results

1 reference

12 December 2020

Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial

1 reference

12 December 2020

Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage

1 reference

12 December 2020

The natural history of aneurysms and arteriovenous malformations

1 reference

12 December 2020

Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study

1 reference

12 December 2020

Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group

1 reference

12 December 2020

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial

1 reference

12 December 2020

Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study

1 reference

12 December 2020

Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: A double-blind clinical trial

1 reference

12 December 2020

The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms

1 reference

12 December 2020

Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report

1 reference

12 December 2020

Streptokinase clot lysis time in patients with ruptured intracranial aneurysms

1 reference

12 December 2020

Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA)

1 reference

12 December 2020

Spontaneous thrombosis of an intracranial aneurysm during treatment with epsilon aminocaproic acid

1 reference

12 December 2020

Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy

1 reference

12 December 2020

The risk of rebleeding from ruptured intracranial aneurysms

1 reference

12 December 2020

Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocapproic acid

1 reference

12 December 2020

Myopathy induced by epsilon-aminocaproic acid. Case report

1 reference

12 December 2020

Incidence, aetiology, and prognosis of primary subarachnoid haemorrhage. A study based on 589 cases diagnosed in a defined urban population during a defined period

1 reference

12 December 2020

Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage

1 reference

12 December 2020

Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases

1 reference

12 December 2020

Epsilon aminocaproic acid (EACA) myopathy

1 reference

12 December 2020

Outcome 1 year after SAH from cerebral aneurysm. Management morbidity, mortality, and functional status in 112 consecutive good-risk patients

1 reference

12 December 2020

Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management

1 reference

12 December 2020

Calcium antagonists for aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

Fibrinolytic activity of the spinal fluid and meninges

1 reference

12 December 2020

Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study

1 reference

12 December 2020

Acute renal failure and myopathy after treatment with aminocaproic acid

1 reference

12 December 2020

The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

Rebleeding of ruptured intracranial aneurysms in the acute stage

1 reference

12 December 2020

Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm

1 reference

12 December 2020

The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms

1 reference

12 December 2020

Monitoring antifibrinolytic therapy in subarachnoid hemorrhage

1 reference

12 December 2020

The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Ultra-early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 patients not selected by grade or age.

1 reference

12 December 2020

Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor

1 reference

12 December 2020

Thrombosis with epsilon aminocaproic acid therapy

1 reference

12 December 2020

Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review

1 reference

12 December 2020

Ultra-early rebleeding in spontaneous subarachnoid hemorrhage

1 reference

12 December 2020

High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage

1 reference

12 December 2020

Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study

1 reference

12 December 2020

Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid

1 reference

12 December 2020

Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms

1 reference

12 December 2020

Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage

1 reference

12 December 2020

10.1007/S12028-008-9088-5

Identifiers

DOI

1 reference

18 August 2017

1 reference